These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 12447697)
1. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway. Kwong KY; Zou Y; Day CP; Hung MC Oncogene; 2002 Nov; 21(54):8340-6. PubMed ID: 12447697 [TBL] [Abstract][Full Text] [Related]
2. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. Chen RH; McCormick F Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074 [TBL] [Abstract][Full Text] [Related]
3. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053 [TBL] [Abstract][Full Text] [Related]
5. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655 [TBL] [Abstract][Full Text] [Related]
6. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. Green DW; Roh H; Pippin JA; Drebin JA J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549 [TBL] [Abstract][Full Text] [Related]
8. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics. Wakita K; Tetsu O; McCormick F Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869 [TBL] [Abstract][Full Text] [Related]
9. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341 [TBL] [Abstract][Full Text] [Related]
10. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Kuroda T; Rabkin SD; Martuza RL Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077 [TBL] [Abstract][Full Text] [Related]
11. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related]
12. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383 [TBL] [Abstract][Full Text] [Related]
13. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519 [TBL] [Abstract][Full Text] [Related]
14. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Verma UN; Surabhi RM; Schmaltieg A; Becerra C; Gaynor RB Clin Cancer Res; 2003 Apr; 9(4):1291-300. PubMed ID: 12684397 [TBL] [Abstract][Full Text] [Related]
15. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908 [TBL] [Abstract][Full Text] [Related]
16. Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Sekine S; Shibata T; Sakamoto M; Hirohashi S Oncogene; 2002 Aug; 21(38):5906-11. PubMed ID: 12185590 [TBL] [Abstract][Full Text] [Related]
17. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]. Brabletz T; Jung A; Dag S; Reu S; Kirchner T Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy approach in prostate cancer cells using an active Wnt signal. Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787 [TBL] [Abstract][Full Text] [Related]
20. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]